Core Insights - Many fund managers issued "apology letters" in their 2025 semi-annual reports, reflecting underperformance and the challenges faced in a rapidly changing A-share market [2][3] - The apologies highlight individual judgment errors and the broader issues of valuation system reconstruction and investment paradigm shifts [2][3] Group 1: Fund Performance and Apologies - Fund manager Fu Hongzhe of Taikang Medical Health Fund acknowledged underperformance, attributing it to overly conservative operations and missed opportunities in innovative drug assets [3][4] - Xu Jun from Guolianan Fund also apologized for the underperformance of his fund, citing a strategy that failed to adapt to the "stronger get stronger" market dynamics [5][6] - Even funds that achieved positive returns, like Huaxia Fund's Xu Xiaohui, expressed regret for not meeting expectations due to underestimating market valuation fluctuations [5][6] Group 2: Investment Strategy Reflections - Fund managers' apologies have sparked discussions on the need for deeper reflections on investment strategies and market adaptability [6][7] - Key areas of misjudgment included excessive concern over geopolitical risks, premature sector switching, and insensitivity to changes in valuation systems [6][7] - The industry is witnessing a shift towards greater transparency and accountability among fund managers, which may foster trust and promote healthy industry development [7] Group 3: Market Outlook and Challenges - The market is expected to face uncertainties in the second half of the year, including macroeconomic recovery, policy implementation, and international relations [7] - Fund managers will be tested on their ability to navigate complex environments while maintaining strategy stability and flexibility [7]